An Open-label, Randomized, Single-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin in Healthy Male Volunteers

NCT02140489 Phase 1 UNKNOWN

The purpose of this study is to evaluate the drug-drug interaction between amlodipine/losartan and rosuvastatin in healthy male volunteers.

Details

Lead sponsor	Hanmi Pharmaceutical Company Limited
Phase	Phase 1
Status	UNKNOWN
Enrolment	30
Start date	2014-02
Completion	2014-08

Conditions

• Healthy

Interventions

• amosartan
• rosuvastatin
• amosartan and rosuvastatin

Primary outcomes

• Cmax — 0-72h
• AUClast — 0-72h

Countries

South Korea